ACTN4 and cervical carcinoma: NHERF1 was further demonstrated to retard cell proliferation with the attenuation of Wnt/β-catenin pathway activation of cervical cancer cells in vivo and in vitro through suppression of α-actinin-4 (ACTN4) expression level.